Abstract
Acute lung injury is accompanied by an increased endothelial chemokine production and adhesion molecule expression, which may result in an extensive neutrophil infiltration. Moreover, a destruction of the alveolar epithelium and capillary endothelium may result in permeability edema. As such, the search for novel anti-inflammatory substances, able to downregulate these parameters as well as the tissue damage holds therapeutic promise. We therefore describe here the use of human endothelial cell-based in vitro assays for the detection of anti-inflammatory and wound-healing metabolites from cyanobacteria.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acute Lung Injury / drug therapy
-
Acute Lung Injury / physiopathology
-
Anti-Inflammatory Agents / isolation & purification
-
Anti-Inflammatory Agents / pharmacology*
-
Cell Line
-
Endothelial Cells / drug effects
-
Endothelial Cells / metabolism
-
Gene Expression Regulation
-
Humans
-
Intercellular Adhesion Molecule-1 / metabolism
-
Models, Biological*
-
Neutrophil Infiltration / drug effects
-
Nostoc / chemistry*
-
Nostoc / metabolism
-
Pulmonary Alveoli / drug effects
-
Pulmonary Alveoli / physiopathology
-
Wound Healing / drug effects*
Substances
-
Anti-Inflammatory Agents
-
Intercellular Adhesion Molecule-1